What mechanisms contribute to antibiotic resistance in dental plaque biofilms?

• A. Increased antibiotic diffusion, rapid growth
• B. Reduced penetration, slow-growing persister cells, efflux pumps, and horizontal gene transfer within the biofilm
• C. Only mutation of ribosomal targets
• D. Absence of any biofilm-specific resistance

Answer: (B)

Antibiotic resistance in dental plaque biofilms arises from several biofilm-specific defenses that work together to blunt drug effectiveness. The extracellular polymeric matrix and the structured architecture of the biofilm hinder antibiotic diffusion, creating gradients where deeper layers are exposed to much lower concentrations than the surface. This reduced penetration means that many bacteria in the core of the biofilm experience sublethal doses, allowing survival and recovery after treatment.

In addition, cells within the biofilm often grow slowly or enter dormant persister states due to limited nutrients and waste buildup. Many antibiotics target active cellular processes, so these slow- or non-growing cells are inherently more tolerant and can repopulate once the antibiotic is removed.

Efflux pumps present in many biofilm bacteria actively export antibiotics from the cell, lowering intracellular drug levels and contributing to a tolerant phenotype that persists even when some growth occurs.

Finally, horizontal gene transfer is facilitated in the dense, closely packed community of a biofilm. Conjugation, transformation, and transduction enable rapid spread of resistance genes and mobile genetic elements, disseminating resistance traits throughout the plaque community.

Put together, these mechanisms—reduced penetration, persister cells, efflux activity, and gene transfer within the biofilm—best explain why dental plaque biofilms exhibit robust antibiotic resistance. The other scenarios fail to account for the biofilm-specific features that drive this tolerance, such as diffusion barriers, metabolic heterogeneity, and gene exchange.